Us Bancorp »

Cerevel Therapeutics Hldng I shares owned by Us Bancorp

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Us Bancorp

Quarter filed Position value Share count Share price at filing
2023-12-31 $22k 517 42.40
2023-09-30 $3.4k 157 21.83
2022-12-31 $1.7k 55 31.55

More positions owned by Us Bancorp

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Rus Mid Cap Etf (IWR)
Eli Lilly & Co. (LLY)
Ishares Core Msci Emkt (IEMG)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr National Mun Etf (MUB)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Us Bancorp

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I